Nexeon MedSystems Inc. (NXNN)

USD 0.0

(0.0%)

Market Cap (In USD)

78.62 Thousand

Revenue (In USD)

3.3 Million

Net Income (In USD)

-2.17 Million

Avg. Volume

-

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.0E-4-1.0E-4
PE
-
EPS
-
Beta Value
6.273
ISIN
US65342G2030
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. William Rosellini J.D., M.B.A., M.S.
Employee Count
-
Website
https://www.nexeonmedsystems.com
Ipo Date
2017-09-27
Details
Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.